MedTrace Logo

Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian Population

NCT03799185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13610

Last updated 2020-01-22

No results posted yet for this study

Summary

ATERA Survey is a national cross sectional observational study, aiming to determine the prevalence of dyslipidemia and other conventional risk factors for CHD (Coronary Heart Disease), the relationship between environmental and lifestyle factors with dyslipidemia, the perception and the knowledge of cardiovascular risk factors by the population, and above all, to strengthen the national strategy for primary and secondary prevention against coronary heart disease.

Conditions

Sponsors & Collaborators

  • Biochimie Clinique LR99ES11

    collaborator UNKNOWN

  • Department of Biochemistry, La Rabta Hospital, Tunisia.

    collaborator UNKNOWN

  • Ministry of Health, Tunisia

    collaborator UNKNOWN

  • Ministry of Interior, Tunisia

    collaborator UNKNOWN

  • Direction des Soins de Santé de Base

    collaborator OTHER_GOV

  • National Institute of Statistics

    collaborator UNKNOWN

  • National Institute of Public Health of Tunisia

    collaborator UNKNOWN

  • Dacima Consulting

    collaborator OTHER

  • Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose

    lead OTHER

Principal Investigators

  • Amani Kallel, PhD · Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose

  • Riadh Jemaa, PhD · Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-04
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03799185 on ClinicalTrials.gov